| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |